MULTIPLAN CORP (MPLN)
US62548M1009 - Common Stock
Overall MPLN gets a fundamental rating of 2 out of 10. We evaluated MPLN against 37 industry peers in the Health Care Technology industry. There are concerns on the financial health of MPLN while its profitability can be described as average. MPLN does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
MPLN had negative earnings in the past year.
In the past year MPLN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MPLN reported negative net income in multiple years.
Each year in the past 5 years MPLN had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of -20.41%, MPLN perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
MPLN has a worse Return On Equity (-194.23%) than 83.33% of its industry peers.
MPLN has a better Return On Invested Capital (2.03%) than 88.89% of its industry peers.
MPLN had an Average Return On Invested Capital over the past 3 years of 3.20%. This is below the industry average of 6.15%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.41% | ||
| ROE | -194.23% | ||
| ROIC | 2.03% |
ROA(3y)-2.62%
ROA(5y)-2.8%
ROE(3y)-11%
ROE(5y)-10.57%
ROIC(3y)3.2%
ROIC(5y)N/A
1.3 Margins
MPLN's Operating Margin of 14.96% is amongst the best of the industry. MPLN outperforms 94.44% of its industry peers.
MPLN has a Gross Margin of 74.55%. This is in the better half of the industry: MPLN outperforms 75.00% of its industry peers.
In the last couple of years the Gross Margin of MPLN has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.96% | ||
| PM (TTM) | N/A | ||
| GM | 74.55% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.58%
GM growth 5YN/A
2. Health
2.1 Basic Checks
MPLN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MPLN has less shares outstanding than it did 1 year ago.
MPLN has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of -0.13, we must say that MPLN is in the distress zone and has some risk of bankruptcy.
MPLN has a Altman-Z score (-0.13) which is comparable to the rest of the industry.
The Debt to FCF ratio of MPLN is 77.64, which is on the high side as it means it would take MPLN, 77.64 years of fcf income to pay off all of its debts.
MPLN's Debt to FCF ratio of 77.64 is in line compared to the rest of the industry. MPLN outperforms 55.56% of its industry peers.
MPLN has a Debt/Equity ratio of 7.48. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of MPLN (7.48) is worse than 86.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.48 | ||
| Debt/FCF | 77.64 | ||
| Altman-Z | -0.13 |
ROIC/WACC0.35
WACC5.81%
2.3 Liquidity
MPLN has a Current Ratio of 1.06. This is a normal value and indicates that MPLN is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.06, MPLN is doing worse than 63.89% of the companies in the same industry.
MPLN has a Quick Ratio of 1.06. This is a normal value and indicates that MPLN is financially healthy and should not expect problems in meeting its short term obligations.
MPLN has a Quick ratio of 1.06. This is in the lower half of the industry: MPLN underperforms 63.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 |
3. Growth
3.1 Past
MPLN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.81%.
MPLN shows a decrease in Revenue. In the last year, the revenue decreased by -1.17%.
The Revenue has been growing slightly by 0.84% on average over the past years.
EPS 1Y (TTM)3.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1383.33%
Revenue 1Y (TTM)-1.17%
Revenue growth 3Y0.84%
Revenue growth 5YN/A
Sales Q2Q%-1.9%
3.2 Future
MPLN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -12.81% yearly.
Based on estimates for the next years, MPLN will show a small growth in Revenue. The Revenue will grow by 0.62% on average per year.
EPS Next Y-2280%
EPS Next 2Y-18.98%
EPS Next 3Y-12.81%
EPS Next 5YN/A
Revenue Next Year-2.61%
Revenue Next 2Y-1%
Revenue Next 3Y0.62%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MPLN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MPLN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
MPLN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MPLN is cheaper than 94.44% of the companies in the same industry.
MPLN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MPLN is cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 2.48 | ||
| EV/EBITDA | 8.12 |
4.3 Compensation for Growth
A cheap valuation may be justified as MPLN's earnings are expected to decrease with -12.81% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-18.98%
EPS Next 3Y-12.81%
5. Dividend
5.1 Amount
MPLN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MULTIPLAN CORP
NYSE:MPLN (11/4/2024, 8:24:26 PM)
After market: 8.4 -0.4 (-4.55%)8.8
-0.36 (-3.93%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap144.76M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.41% | ||
| ROE | -194.23% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 14.96% | ||
| PM (TTM) | N/A | ||
| GM | 74.55% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.17
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 7.48 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.06 | ||
| Quick Ratio | 1.06 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)3.81%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-2280%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.17%
Revenue growth 3Y0.84%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y